Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
January 9, 2017
Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
Michael J Pontecorvo, Anupa K Arora, Marybeth Devine, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
February 22, 2021
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
Jennifer A Zimmer, Sergey Shcherbinin, Michael D Devous, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET
William E Klunk, Robert A Koeppe, Julie C Price, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 21, 2018
Parametric methods for [<sup>18</sup>F]flortaucipir PET
Sandeep Sv Golla, Emma E Wolters, Tessa Timmers, et al.
Archives of Neurology
|
May 14, 2008
Diffusion tensor tractography of traumatic diffuse axonal injury
Jun Yi Wang, Khamid Bakhadirov, Michael D Devous, et al.
JAMA Neurology
|
February 15, 2021
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials
Ming Lu, Michael J Pontecorvo, Michael D Devous, et al.
The New England Journal of Medicine
|
April 11, 2019
Tau Positron-Emission Tomography in Former National Football League Players
Robert A Stern, Charles H Adler, Kewei Chen, et al.
Brain : a Journal of Neurology
|
April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
Nature Medicine
|
April 30, 2021
Four distinct trajectories of tau deposition identified in Alzheimer's disease
Jacob W Vogel, Alexandra L Young, Neil P Oxtoby, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
European Journal of Nuclear Medicine and Molecular Imaging
|
January 9, 2017
Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
Michael J Pontecorvo, Anupa K Arora, Marybeth Devine, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
February 22, 2021
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
Jennifer A Zimmer, Sergey Shcherbinin, Michael D Devous, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET
William E Klunk, Robert A Koeppe, Julie C Price, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 21, 2018
Parametric methods for [<sup>18</sup>F]flortaucipir PET
Sandeep Sv Golla, Emma E Wolters, Tessa Timmers, et al.
Archives of Neurology
|
May 14, 2008
Diffusion tensor tractography of traumatic diffuse axonal injury
Jun Yi Wang, Khamid Bakhadirov, Michael D Devous, et al.
JAMA Neurology
|
February 15, 2021
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials
Ming Lu, Michael J Pontecorvo, Michael D Devous, et al.
The New England Journal of Medicine
|
April 11, 2019
Tau Positron-Emission Tomography in Former National Football League Players
Robert A Stern, Charles H Adler, Kewei Chen, et al.
Brain : a Journal of Neurology
|
April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
Nature Medicine
|
April 30, 2021
Four distinct trajectories of tau deposition identified in Alzheimer's disease
Jacob W Vogel, Alexandra L Young, Neil P Oxtoby, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Page
of 8